InvestorsHub Logo
Followers 839
Posts 120535
Boards Moderated 14
Alias Born 09/05/2002

Re: Tha Part Time Er post# 4312

Monday, 08/10/2020 1:13:16 PM

Monday, August 10, 2020 1:13:16 PM

Post# of 4876
GILD submits NDA for Veklury (Remdesivir):

https://www.businesswire.com/news/home/20200810005486/en

Remdesivir has an Emergency Use Authorization, but this NDA seeks to obtain full-fledged FDA approval for treatment of COVID-19. The drug already has full approval in the EU and Japan, among other places.

GILD continues to work on an inhaled formulation (#msg-156430406).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News